How to Build and Sell a Biotech in 2024
Strategic Alternatives
Analysis of FTC and Anti-trust Regulations in Biotech Sector
Exploring the implications of FTC scrutiny and anti-trust regulations in the biotech sector, with a focus on operational disruptions and the rarity of second requests. The chapter underscores the multi-faceted nature of deal determinants beyond just FTC oversight.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
